Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design-Reference-Cited by-同舟云学术

Progression-free and overall survival in patients with relapsed/refractory germ cell tumors treated with single-agent chemotherapy: Endpoints for clinical trial design

Published:2011-07-26 Issue:4 Volume:118 Page:981-986
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Feldman Darren R.,Patil Sujata,Trinos Michael J.,Carousso Maryann,Ginsberg Michelle S.,Sheinfeld Joel,Bajorin Dean F.,Bosl George J.,Motzer Robert J.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26375/fullpdf

Reference16 articles.

1. Medical treatment of advanced testicular cancer;Feldman;JAMA,2008

2. National Cancer Institute 2006 http://seer. cancer.gov/csr/1975_2004/results_figure/sect_01_zfig.19.pdf

3. Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group;Kollmannsberger;J Clin Oncol,2004

4. Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor;De Giorgi;Eur Urol,2006

5. Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study;Pectasides;Ann Oncol,2004

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biology and epigenetic modifications definition;Genetics and Epigenetics of Genitourinary Diseases;2025

2. Unwrapping the immunological alterations in testicular germ cell tumors: From immune homeostasis to malignancy and emerging immunotherapies;Andrology;2024-09-10

3. Expression of CD44 is associated with aggressiveness in seminomas;Molecular Biology Reports;2024-05-25

4. Emergent Management of Growing Teratoma Syndrome: A Case Presentation;Cureus;2024-04-30

5. The Immune Landscape and Immunotherapeutic Strategies in Platinum-Refractory Testicular Germ Cell Tumors;Cancers;2024-01-19